We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are ...

We recently published a list of 10 Best Stocks to Invest in for Long Term. In this article, we are going to take a look at ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 ...

Eli Lilly’s Verzenio is already one of its fastest-growing products, but could go up another gear following a pair of FDA approvals that expand its eligible patient population – particularly ...

Thanks to David Krumholtz of "The Santa Clause" fame, we've gotten our very first glimpse at the official logo for next year's "Supergirl: Woman of Tomorrow"... or perhaps just "Supergirl"?

Drake University and Des Moines Area Community College could be close to a settlement agreement in a hotly contested legal battle over the schools' logos and trademarks. New court records show a ...

His infamous sketch in the back of a yellow cab became the most imitated logo in history—and cities are still copying it today. In the summer of 1977, New York City was burning. A 25-hour ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The report provides product descriptions, patent details, and ...

The logos of Big Tech companies and key associations were featured prominently Monday at the White House Easter Egg Roll, offering an unprecedented scene and use of the grounds to promote private ...

Eli Lilly's oral GLP-1 medicine aced a phase 3 study. It should become a new growth driver for the company. There are other reasons to invest in the pharmaceutical leader. Zepbound's prospects ...

Consider Verzenio, a cancer drug. Last year, its sales soared by 37% year over year to $5.3 billion. Taltz, Lilly's immunosuppressant, reported revenue of $3.3 billion last year, 18% higher than ...